½ÃÀ庸°í¼­
»óǰÄÚµå
1423959

±Û·çÄÚ»ç¹Î ½ÃÀå, Á¡À¯À², ±Ô¸ð, µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2032³â)

Glucosamine Market Share, Size, Trends, Industry Analysis Report, By Product, By Application, By Region, And Segment Forecasts, 2024 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Polaris Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 115 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¼¼°è ±Û·çÄÚ»ç¹Î ½ÃÀå ±Ô¸ð´Â 2032³â±îÁö 13¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ¹Ì·¡ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ÀÌ Á¦Ç°Àº °Ç°­º¸Á¶½Äǰ Á¦Á¶¿¡ Àû¿ë ¹üÀ§°¡ È®´ëµÇ°í ÀÖÀ¸¸ç, ƯÈ÷ ¼ÒºñÀÚµé »çÀÌ¿¡¼­ °ñ°üÀý¿° ¿¹¹æÀ» À§ÇÑ °Ç°­º¸Á¶½Äǰ¿¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÀ¿ë ¹üÀ§ÀÇ È®´ë´Â ÇâÈÄ ¸î ³âµ¿¾È ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °üÀý °Ç°­°ú °ñ°üÀý¿° ¿¹¹æ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼ÒºñÀÚµéÀº È¿°úÀûÀÎ ÇØ°áÃ¥À» ã°í ÀÖ½À´Ï´Ù. ÀÌ Á¦Ç°À» Æ÷ÇÔÇÑ °Ç°­ º¸Á¶ ½ÄǰÀº °ñ°üÀý¿° ¿¹¹æ¿¡ µµ¿òÀÌ µÉ ¼ö Àֱ⠶§¹®¿¡ Á¡Á¡ ´õ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. Àû±ØÀûÀÎ °üÀý °ü¸®ÀÇ Á߿伺À» ÀνÄÇÏ°í ¿¹¹æÃ¥À¸·Î °Ç°­±â´É½ÄǰÀ» ÀÌ¿ëÇÏ´Â »ç¶÷µéÀÌ ´Ã¾î³²¿¡ µû¶ó ÀÌ·¯ÇÑ ¼ö¿ä´Â Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ¿¡ µû¶ó, ÀÌ Á¦Ç°ÀÌ ÀÌ·¯ÇÑ º¸ÃæÁ¦¿¡ Æ÷ÇԵǸé ÇâÈÄ ¸î ³âµ¿¾È ½ÃÀå¿¡¼­ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ä½ÄÁÖÀÇÀÚ Áõ°¡·Î ÀÎÇØ ÀÌ »ê¾÷Àº ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â ä½ÄÁÖÀÇÀÚµéÀÇ ½Ä½À°üÀ» ÃæÁ·½ÃŰ´Â Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Á¦Ç°Àº ÀüÅëÀûÀ¸·Î »õ¿ì³ª °Ô¿Í °°Àº °©°¢·ù¿¡¼­ ÃßÃâÇÑ °ÍÀÌÁö¸¸, Cargill°ú Cyanotech¿Í °°Àº ȸ»ç´Â ä½ÄÁÖÀÇÀÚ ±Û·çÄÚ»ç¹ÎÀ» °³¹ßÇÏ¿© ¼±±¸ÀûÀÎ Á¢±Ù ¹æ½ÄÀ» µµÀÔÇß½À´Ï´Ù. ÀÌ Çõ½ÅÀº '¾Æ½ºÆä¸£±æ·ç½º ´Ï°Å(Aspergillus niger)'¶ó´Â ±Õ·ù¿¡¼­ ¼ººÐÀ» ÃßÃâÇÏ¿© ä½ÄÁÖÀÇÀÚ ¼ÒºñÀÚÀÇ ÃëÇâ¿¡ ¸Â´Â ½Ä¹°¼º ´ëüǰÀ» Á¦°øÇÕ´Ï´Ù.

¼¼°è Àα¸ Áõ°¡, ºü¸£°Ô ¼ºÀåÇÏ´Â ÇコÄÉ¾î ºÐ¾ß, °üÀý ¹× »À °Ç°­¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ´Ù¾çÇÑ ½Äǰ ¹× À½·á¿¡ ±Û·çÄÚ»ç¹ÎÀ» ÷°¡ÇÏ´Â °ÍÀÌ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, À½·á ¹× ½Äǰ Á¦Á¶¿¡ ±Û·çÄÚ»ç¹ÎÀ» »ç¿ëÇÏ´Â ¼±Áø±¹ÀÇ Áö¿øÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â ÇâÈÄ 7³â°£ »ê¾÷ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±×·¯³ª, µµÀü°úÁ¦µµ ÀÖ½À´Ï´Ù. °üÀý °Ç°­¿¡ µµ¿òÀÌ µÇ´Â ¾îÀ¯³ª ¿À¸Þ°¡3¿Í °°Àº ´ëüǰÀÇ À§ÇùÀÌ Áõ°¡Çϸ鼭 ¿¹Ãø ±â°£ µ¿¾È ±Û·çÄÚ»ç¹Î ÇÔÀ¯ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ À§ÇùÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼ÒºñÀÚÀÇ ¼±ÅÃÀÇ ÆøÀÌ ³Ð¾îÁü¿¡ µû¶ó ±Û·çÄÚ»ç¹Î ÇÔÀ¯ Á¦Ç° ½ÃÀåÀº ÀÌ·¯ÇÑ ´ëüǰ°úÀÇ °æÀï¿¡ Á÷¸éÇÏ¿© À½·á ¹× ½Äǰ »ê¾÷¿¡¼­ ±Û·çÄÚ»ç¹Î¿¡ ´ëÇÑ Àüü ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

±Û·çÄÚ»ç¹Î ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

±Û·çÄÚ»ç¹Î Ȳ»ê¿° ºÎ¹®Àº ½ÄÀÌ ¿ä¹ý ¹× Á¦¾à ÀÀ¿ë ºÐ¾ß¿¡¼­ ³Î¸® »ç¿ëµÇ±â ¶§¹®¿¡ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.

±Û·çÄÚ»ç¹Î ¿°»ê¿° ºÎ¹®Àº °üÀý °Ç°­À» À§ÇÑ ¿µ¾ç ¼ººÐÀ¸·Î ³Î¸® »ç¿ëµÇ°í Àֱ⠶§¹®¿¡ »ó´çÇÑ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°Ç°­º¸Á¶½ÄǰÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí Àִµ¥, ÀÌ´Â ÁÖ·Î ÀÏ»ó ½Ä´Ü¿¡¼­ ½Äǰ º¸ÃæÁ¦·Î »ç¿ëµÇ±â ¶§¹®ÀÔ´Ï´Ù.

Àα¸ Áõ°¡, °¡Ã³ºÐ ¼Òµæ Áõ°¡, ¼ÒºñÀÚ °Ç°­ ¹× ÀÎ½Ä Áõ°¡·Î ÀÎÇØ ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ½ÃÀåÀ» Àå¾ÇÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ±Û·çÄÚ»ç¹Î ½ÃÀå ÀλçÀÌÆ®

  • ±Û·çÄÚ»ç¹Î ½ÃÀå - ¾÷°è ÇöȲ
  • ±Û·çÄÚ»ç¹Î ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
  • PESTLE ºÐ¼®
  • ±Û·çÄÚ»ç¹Î ¾÷°è µ¿Çâ
  • ¹ë·ùüÀÎ ºÐ¼®
  • COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ±Û·çÄÚ»ç¹Î ½ÃÀå, Á¦Ç°º°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • ±Û·çÄÚ»ç¹Î Ȳ»ê¿°
  • ±Û·çÄÚ»ç¹Î ¿°»ê¿°
  • N-¾Æ¼¼Æ¿±Û·çÄÚ»ç¹Î
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ±Û·çÄÚ»ç¹Î ½ÃÀå, ¿ëµµº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
  • º¸ÃæÁ¦
  • ½Äǰ ¹× À½·á
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ±Û·çÄÚ»ç¹Î ½ÃÀå, Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ¼­·Ð
    • ±Û·çÄÚ»ç¹Î ½ÃÀå Æò°¡, Áö¿ªº°, 2019-2032³â
  • ±Û·çÄÚ»ç¹Î ½ÃÀå - ºÏ¹Ì
    • ºÏ¹Ì : ±Û·çÄÚ»ç¹Î ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • ºÏ¹Ì : ±Û·çÄÚ»ç¹Î ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ¹Ì±¹
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ij³ª´Ù
  • ±Û·çÄÚ»ç¹Î ½ÃÀå - À¯·´
    • À¯·´ : ±Û·çÄÚ»ç¹Î ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • À¯·´ : ±Û·çÄÚ»ç¹Î ½ÃÀå, Á¦Ç°º°, 2019-2032
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ¿µ±¹
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ÇÁ¶û½º
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - µ¶ÀÏ
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ÀÌÅ»¸®¾Æ
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ½ºÆäÀÎ
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ³×´ú¶õµå
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ·¯½Ã¾Æ
  • ±Û·çÄÚ»ç¹Î ½ÃÀå - ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±Û·çÄÚ»ç¹Î ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±Û·çÄÚ»ç¹Î ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - Áß±¹
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - Àεµ
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ¸»·¹À̽þÆ
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ÀϺ»
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - Àεµ³×½Ã¾Æ
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - Çѱ¹
  • ±Û·çÄÚ»ç¹Î ½ÃÀå - Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±Û·çÄÚ»ç¹Î ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±Û·çÄÚ»ç¹Î ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - »ç¿ìµð¾Æ¶óºñ¾Æ
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - À̽º¶ó¿¤
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ³²¾ÆÇÁ¸®Ä«
  • ±Û·çÄÚ»ç¹Î ½ÃÀå - ¶óƾ¾Æ¸Þ¸®Ä«
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±Û·çÄÚ»ç¹Î ½ÃÀå, ¿ëµµº°, 2019-2032³â
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±Û·çÄÚ»ç¹Î ½ÃÀå, Á¦Ç°º°, 2019-2032³â
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ¸ß½ÃÄÚ
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ºê¶óÁú
    • ±Û·çÄÚ»ç¹Î ½ÃÀå - ¾Æ¸£ÇîÆ¼³ª

Á¦8Àå °æÀï ±¸µµ

  • È®Àå ¹× Àμö ºÐ¼®
    • È®Àå
    • Àμö
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³

Á¦9Àå ±â¾÷ °³¿ä

  • Alfa Chemical Group
  • Amway
  • Cargill, Incorporated
  • CELLMARK AB.
  • Golden-Shell Pharmaceutical
  • Koyo Chemical Industry Co., Ltd
  • Laboratoires Expanscience
  • Nutramax Laboratories Consumer Care, Inc.
  • SimplySupplements
LSH 24.02.27

The global glucosamine market size is expected to reach USD 1.39 billion by 2032, according to a new study by Polaris Market Research. The report "Glucosamine Market Share, Size, Trends, Industry Analysis Report, By Product (Glucosamine Sulfate, Glucosamine Hydrochloride, N-acetyl Glucosamine, Others), By Application (Supplement, Food & Beverages, Others), By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The product's usage in the production of nutritional supplements is expanding, specifically in supplements designed to prevent osteoarthritis among consumers. This broadening application scope is anticipated to drive demand in the upcoming years. As awareness about joint health and osteoarthritis prevention grows, consumers are seeking effective solutions. Nutritional supplements containing this product are becoming increasingly popular due to its potential benefits in preventing osteoarthritis. This demand is expected to rise as more people recognize the importance of proactive joint care and turn to nutritional supplements as a preventive measure. Consequently, the product's incorporation in these supplements is expected to fuel its demand in the market over the coming years.

The industry is expected to experience growth due to the rising number of vegan consumers. This trend is anticipated to drive the demand for products that cater to vegan dietary preferences. While the product is traditionally derived from crustaceans such as shrimp and crab, companies like Cargill and Cyanotech have introduced a pioneering approach by developing vegetarian glucosamine. This innovation involves extracting the ingredient from the 'aspergillus niger' fungi, offering a plant-based alternative that aligns with the preferences of vegan consumers.

The rising global population, coupled with the rapidly expanding healthcare sector and growing consumer awareness about joint and bone health, is anticipated to drive the incorporation of glucosamine into a variety of food and beverage products. Furthermore, the supportive regulatory framework in developed nations concerning the use of this ingredient in the production of food and beverages is expected to boost industry growth in the coming seven years.

However, there are challenges on the horizon. The increasing availability of substitutes such as fish oil and omega-3, which also offer joint health benefits, might pose a threat to the demand for glucosamine-containing products in the forecast period. As consumers have more options to choose from, the market for glucosamine-based products could face competition from these alternatives, impacting the overall demand for glucosamine in the food and beverage industry.

Glucosamine Market Report Highlights

Glucosamine sulfate segment dominated the market, as it widely used in the dietary and pharmaceutical applications

Glucosamine hydrochloride segment will grow at substantial pace, owing to its wide usage in dietary ingredient for joint health

Supplements held the largest share, primarily due to its usage in food supplement in daily staples

Asia Pacific dominated the market, owing to rising population, rise in disposable income, and surge in health & awareness among consumers

The global players include Alfa Chemical, Amway, Cargill, CELLMARK, Golden-Shell Pharmaceutical, Koyo Chemical, Laboratoires Expanscience, Nutramax Laboratories Consumer Care, and Simply Supplements.

Polaris Market Research has segmented the glucosamine market report based on product, application, and region:

Glucosamine, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Glucosamine Sulfate
  • Glucosamine Hydrochloride
  • N-acetyl glucosamine
  • Others

Glucosamine, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Supplement
  • Food and Beverage
  • Others

Glucosamine, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Glucosamine Market Insights

  • 4.1. Glucosamine Market - Industry Snapshot
  • 4.2. Glucosamine Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Aging Population
      • 4.2.1.2. Rising Awareness of Health and Wellness
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Allergen Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Glucosamine Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Glucosamine Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Glucosamine, by Product, 2019-2032 (USD Million)
  • 5.3. Glucosamine Sulfate
    • 5.3.1. Global Glucosamine Market, by Glucosamine Sulfate, by Region, 2019-2032 (USD Million)
  • 5.4. Glucosamine Hydrochloride
    • 5.4.1. Global Glucosamine Market, by Glucosamine Hydrochloride, by Region, 2019-2032 (USD Million)
  • 5.5. N-acetyl glucosamine
    • 5.5.1. Global Glucosamine Market, by N-acetyl glucosamine, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Glucosamine Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Glucosamine Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Glucosamine Market, by Application, 2019-2032 (USD Million)
  • 6.3. Supplement
    • 6.3.1. Global Glucosamine Market, by Supplement, by Region, 2019-2032 (USD Million)
  • 6.4. Food and Beverage
    • 6.4.1. Global Glucosamine Market, by Food and Beverage, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Glucosamine Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Glucosamine Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Glucosamine Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Glucosamine Market - North America
    • 7.3.1. North America: Glucosamine Market, by Application, 2019-2032 (USD Million)
    • 7.3.2. North America: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.3.3. Glucosamine Market - U.S.
      • 7.3.3.1. U.S.: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.3.4. Glucosamine Market - Canada
      • 7.3.4.1. Canada: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Glucosamine Market, by Product, 2019-2032 (USD Million)
  • 7.4. Glucosamine Market - Europe
    • 7.4.1. Europe: Glucosamine Market, by Application, 2019-2032 (USD Million)
    • 7.4.2. Europe: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.4.3. Glucosamine Market - UK
      • 7.4.3.1. UK: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.4.4. Glucosamine Market - France
      • 7.4.4.1. France: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.4.4.2. France: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.4.5. Glucosamine Market - Germany
      • 7.4.5.1. Germany: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.4.6. Glucosamine Market - Italy
      • 7.4.6.1. Italy: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.4.7. Glucosamine Market - Spain
      • 7.4.7.1. Spain: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.4.8. Glucosamine Market - Netherlands
      • 7.4.8.1. Netherlands: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.4.9. Glucosamine Market - Russia
      • 7.4.9.1. Russia: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Glucosamine Market, by Product, 2019-2032 (USD Million)
  • 7.5. Glucosamine Market - Asia Pacific
    • 7.5.1. Asia Pacific: Glucosamine Market, by Application, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.5.3. Glucosamine Market - China
      • 7.5.3.1. China: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.5.3.2. China: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.5.4. Glucosamine Market - India
      • 7.5.4.1. India: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.5.4.2. India: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.5.5. Glucosamine Market - Malaysia
      • 7.5.5.1. Malaysia: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.5.6. Glucosamine Market - Japan
      • 7.5.6.1. Japan: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.5.7. Glucosamine Market - Indonesia
      • 7.5.7.1. Indonesia: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.5.8. Glucosamine Market - South Korea
      • 7.5.8.1. South Korea: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Glucosamine Market, by Product, 2019-2032 (USD Million)
  • 7.6. Glucosamine Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Glucosamine Market, by Application, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.6.3. Glucosamine Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.6.4. Glucosamine Market - UAE
      • 7.6.4.1. UAE: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.6.5. Glucosamine Market - Israel
      • 7.6.5.1. Israel: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.6.6. Glucosamine Market - South Africa
      • 7.6.6.1. South Africa: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Glucosamine Market, by Product, 2019-2032 (USD Million)
  • 7.7. Glucosamine Market - Latin America
    • 7.7.1. Latin America: Glucosamine Market, by Application, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.7.3. Glucosamine Market - Mexico
      • 7.7.3.1. Mexico: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.7.4. Glucosamine Market - Brazil
      • 7.7.4.1. Brazil: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Glucosamine Market, by Product, 2019-2032 (USD Million)
    • 7.7.5. Glucosamine Market - Argentina
      • 7.7.5.1. Argentina: Glucosamine Market, by Application, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Glucosamine Market, by Product, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Alfa Chemical Group
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Amway
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Cargill, Incorporated
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. CELLMARK AB.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Golden-Shell Pharmaceutical
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Koyo Chemical Industry Co., Ltd
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Laboratoires Expanscience
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Nutramax Laboratories Consumer Care, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. SimplySupplements
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦